Exclusive

Publication

Byline

Vetter starts construction of new facility in Germany for production of injectable drugs

Singapore, May 14 -- Vetter, a leading Contract Development and Manufacturing Organization (CDMO), has announced the start of construction on its new site in Saarlouis with a traditional groundbreakin... Read More


Korea lays focus on development of public medical care and enhancement of medical training

Singapore, May 13 -- Korea University's College of Medicine and Armed Forces Capital Hospital have signed a Memorandum of Understanding (MoU) for the development of public health and medical care, as ... Read More


Singapore and China renew commitment in enhancing regulatory collaboration on health products

Singapore, May 13 -- Singapore's Health Sciences Authority (HSA) and China's National Medical Products Administration (NMPA) have signed a Memorandum of Understanding (MoU) to renew their commitment i... Read More


Hokkaido University leverages BostonGene's AI-powered platform to advance precision oncology

Singapore, May 13 -- US-based BostonGene, developer of the leading AI foundation model for tumour and immune biology, has announced the expanded strategic research collaboration with Japan's Hokkaido ... Read More


GSK enters exclusive collaboration with SBP Group to accelerate hepatitis B treatment in China

Singapore, May 13 -- GSK plc has entered into an exclusive strategic collaboration with Sino Biopharmaceutical (SBP Group), through its subsidiary Chia Tai Tianqing Pharmaceutical Group (CTTQ), to acc... Read More


Monash University leads effort to rename Polycystic Ovary Syndrome (PCOS) as Polyendocrine Metabolic Ovarian Syndrome (PMOS)

Singapore, May 13 -- Polycystic Ovary Syndrome (PCOS) has been renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS), following a 14-year global effort, led by Monash University in Australia, to imp... Read More


HGP2 Rare Disease Alliance of Asia-Pacific Region launches in Malaysia

Singapore, May 13 -- The HGP2 Rare Disease Alliance of the Asia-Pacific Region (HGP2 RaDiAnce-APAC) was officially launched in Kuala Lumpur, Malaysia on May 10. Dr Nor Fariza Binti Ngah, Deputy Direc... Read More


CEL-SCI enters strategic agreement with Amarox for commercialisation and distribution of Multikine in Saudi Arabia

Singapore, May 12 -- US-baed CEL-SCI Corporation has signed a strategic partnership, distribution, and revenue sharing agreement with Amarox for regulatory affairs, marketing and potential commerciali... Read More


Australia injects $7.4 M in ground-breaking medical devices

Singapore, May 12 -- An artificial intelligence (AI)-powered medical system to provide life-saving early warning for serious complications in pregnancy and childbirth is one of four ground-breaking me... Read More


Taiwan's Bora Group buys MacroGenics' GMP manufacturing operations for $122.5 M

Singapore, May 12 -- Taiwan-based Bora Pharmaceuticals announced that its Board of Directors has approved the acquisition of the GMP manufacturing operations, including the CDMO business, of MacroGeni... Read More